Jason Zemansky
Stock Analyst at Bank of America Securities
(4.73)
# 705
Out of 5,051 analysts
462
Total ratings
53%
Success rate
16.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jason Zemansky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNDX Syndax Pharmaceuticals | Reiterated: Buy | $26 → $23 | $16.55 | +38.97% | 36 | Oct 13, 2026 | |
| INSM Insmed | Reiterated: Buy | $214 → $207 | $98.56 | +110.02% | 53 | Oct 12, 2026 | |
| RCKT Rocket Pharmaceuticals | Reiterated: Buy | $10 | $2.48 | +303.23% | 21 | Oct 7, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | $104 | $65.75 | +58.17% | 38 | Oct 6, 2026 | |
| RCUS Arcus Biosciences | Reiterated: Hold | $29 | $24.34 | +19.15% | 39 | Oct 5, 2026 | |
| KURA Kura Oncology | Reiterated: Buy | $31 | $10.40 | +198.22% | 42 | Sep 29, 2026 | |
| EIKN Eikon Therapeutics | Reiterated: Buy | $32 | $7.26 | +340.77% | 4 | Sep 28, 2026 | |
| TVTX Travere Therapeutics | Reiterated: Buy | $71 | $52.02 | +36.49% | 31 | Sep 23, 2026 | |
| LGND Ligand Pharmaceuticals | Reiterated: Buy | $388 | $311.13 | +24.71% | 11 | Sep 22, 2026 | |
| ABOS Acumen Pharmaceuticals | Reiterated: Buy | $8 | $2.02 | +296.04% | 14 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 | $19.60 | +98.98% | 17 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $85 | $62.79 | +35.37% | 50 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $17 | $11.61 | +46.43% | 17 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $12 | $8.27 | +45.10% | 12 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $553 → $543 | $467.16 | +16.23% | 27 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $215 → $219 | $229.41 | -4.54% | 15 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.85 | +225.20% | 5 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.9818 | +612.98% | 19 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $55.39 | n/a | 2 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $15 → $12 | $2.42 | n/a | 4 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1 | $2.26 | n/a | 3 | Dec 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.74 | n/a | 2 | Nov 17, 2023 |
Syndax Pharmaceuticals
Oct 13, 2026
Reiterated: Buy
Price Target: $26 → $23
Current: $16.55
Upside: +38.97%
Insmed
Oct 12, 2026
Reiterated: Buy
Price Target: $214 → $207
Current: $98.56
Upside: +110.02%
Rocket Pharmaceuticals
Oct 7, 2026
Reiterated: Buy
Price Target: $10
Current: $2.48
Upside: +303.23%
BridgeBio Pharma
Oct 6, 2026
Reiterated: Buy
Price Target: $104
Current: $65.75
Upside: +58.17%
Arcus Biosciences
Oct 5, 2026
Reiterated: Hold
Price Target: $29
Current: $24.34
Upside: +19.15%
Kura Oncology
Sep 29, 2026
Reiterated: Buy
Price Target: $31
Current: $10.40
Upside: +198.22%
Eikon Therapeutics
Sep 28, 2026
Reiterated: Buy
Price Target: $32
Current: $7.26
Upside: +340.77%
Travere Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $71
Current: $52.02
Upside: +36.49%
Ligand Pharmaceuticals
Sep 22, 2026
Reiterated: Buy
Price Target: $388
Current: $311.13
Upside: +24.71%
Acumen Pharmaceuticals
Sep 17, 2026
Reiterated: Buy
Price Target: $8
Current: $2.02
Upside: +296.04%
Sep 8, 2026
Reiterated: Buy
Price Target: $39
Current: $19.60
Upside: +98.98%
Aug 31, 2026
Reiterated: Hold
Price Target: $85
Current: $62.79
Upside: +35.37%
Aug 11, 2026
Reiterated: Hold
Price Target: $20 → $17
Current: $11.61
Upside: +46.43%
Aug 11, 2026
Reiterated: Sell
Price Target: $12
Current: $8.27
Upside: +45.10%
Jul 30, 2026
Reiterated: Hold
Price Target: $553 → $543
Current: $467.16
Upside: +16.23%
Jul 29, 2026
Reiterated: Hold
Price Target: $215 → $219
Current: $229.41
Upside: -4.54%
Jul 27, 2026
Reiterated: Buy
Price Target: $6
Current: $1.85
Upside: +225.20%
Feb 17, 2026
Reiterated: Buy
Price Target: $7
Current: $0.9818
Upside: +612.98%
Oct 30, 2024
Reiterated: Buy
Price Target: n/a
Current: $55.39
Upside: n/a
Mar 28, 2024
Reiterated: Sell
Price Target: $15 → $12
Current: $2.42
Upside: n/a
Dec 26, 2023
Reiterated: Sell
Price Target: $1
Current: $2.26
Upside: n/a
Nov 17, 2023
Rated: Hold
Price Target: n/a
Current: $8.74
Upside: n/a